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Numb-dependent integration of pre-TCR and p53
function in T-cell precursor development
NM Martin-Blanco1, S Checquolo2, F Del Gaudio1, R Palermo3, G Franciosa1, L Di Marcotullio1, A Gulino1,4, M Canelles5
and I Screpanti*,1,3,6
Numb asymmetrically segregates at mitosis to control cell fate choices during development. Numb inheritance specifies
progenitor over differentiated cell fates, and, paradoxically, also promotes neuronal differentiation, thus indicating that the role of
Numb may change during development. Here we report that Numb nuclear localization is restricted to early thymocyte precursors,
whereas timed appearance of pre-T-cell receptor (pre-TCR) and activation of protein kinase Cθ promote phosphorylation-
dependent Numb nuclear exclusion. Notably, nuclear localization of Numb in early thymocyte precursors favors p53 nuclear
stabilization, whereas pre-TCR-dependent Numb nuclear exclusion promotes the p53 downmodulation essential for further
differentiation. Accordingly, the persistence of Numb in the nucleus impairs the differentiation and promotes precursor cell death.
This study reveals a novel regulatory mechanism for Numb function based on its nucleus–cytosol shuttling, coupling the different
roles of Numb with different stages of T-cell development.
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Cell fate decision of dividing progenitor-derived cells is a
crucial event in development and diseases. Cell fate is often
regulated by asymmetric cell division, which is a process by
which progenitors asymmetrically segregate certain cell fate
determinants during division, to generate two functionally
different cells.1,2 The adaptor protein Numb was initially
identified in Drosophila as a critical cell fate determinant,3
where loss of Numb and its homolog Numb-like results in the
loss of neural progenitors, indicating that the presence of
Numb is essential for maintaining the progenitors during the
initial progenitor versus neural fate decision.4,5 However,
re-expression of Numb is also required for further neural
differentiation,6,7 indicating that the role of Numb in the same
tissue may change over time.
Numb function in the immune system has been partially
explored.8,9 Numb is involved in asymmetric division in
hematopoietic stem cells,10 thymocytes11 and mature T
lymphocytes.12,13 T cells develop from intrathymic CD4−CD8−
double-negative (DN) precursors that, after progression through
DN1 (CD44+CD25−), DN2 (CD44+CD25+), DN3 (CD44−CD25+)
and DN4 (CD44−CD25−), have to decide between proliferation,
to increase the total number of precursors, or differentiation into
CD4+CD8+ double-positive (DP) cells. This decision is made
during DN3 stage and appears to be dependent on asymmetric
segregation of Numb.11
As Numb is a well-characterized inhibitor of Notch-1
receptor signaling pathway,14 the ability of Numb to regulate
cell fate decisions during development has been associated
with this Numb function.15 However, the role of Numb during
development could not be restricted to the control of Notch-1
signaling, as Numb has been implicated in the regulation of a
variety of biochemical pathways, including the tumor suppres-
sor p53.16 Increasing evidence suggests that p53 regulates
cell differentiation in addition to cell proliferation, apoptosis
and senescence.17,18
Notably, T-cell development is regulated by both Notch-1
and p53. Notch-1 signals appear to be critical for the very early
steps of T-cell development (i.e. T-cell commitment).19 The
involvement of p53 has been instead reported in the transition
from the DN to the DP stage. However, while the over-
expression of p53 during DN3 stage promotes a block in the
differentiation and proliferation, resulting in a small thymus
size,20,21 loss of p53 apparently does not affect thymocyte
development, even though the vast majority of spontaneous
malignancies in p53− /− mice are lymphomas.22 Thus, the
double function of Numb could be dependent on two different
pathways, which may be differentially triggered during
selected differentiation stages.
Recent data describe the presence of Numb in the nuclear
compartment,23 besides its known cytoplasmic localization,
raising the possibility that different Numb functions could be
regulated by its differential subcellular localization. However,
whether Numb may have different subcellular localizations in
precursors or more differentiated T cell, how Numb import is
regulated or how the nuclear localization affects its function
during T-cell development remain unexplored. Here we show
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that Numb is an important regulator of p53 pathway during T-cell
development, and we describe a novel molecular mechanism
involved in the differential regulation of Numb–p53 axis based
on the regulation of Numb nuclear import, emerging an
interesting scenario where Numb can act as a regulator of
two fundamental pathways during T-cell development.
Results
Pre-TCR signaling promotes Numb nuclear exclusion. It
has been recently shown that Numb localizes in the nucleus of
breast cancer cell lines;23 however, no data about nuclear
Numb localization in thymocytes have been reported. We
focused our attention on the DN3 stage of thymocyte
development, as we previously reported that DN3 develop-
ment is dependent on Numb function.11 By confocal micro-
scopy, we examined the subcellular localization of Numb using
frozen sections of day 14 fetal thymi, where most of
thymocytes are DN cells. We used an anti-pre-T-cell recep-
tor-α chain (pTα) antibody to detect DN3-DN4 cells. As DN1
and DN2 thymocytes do not express pTα, negative cells were
considered as DN1-DN2 thymocytes. Nuclear Numb was
found only in pTα− cells (DN1-DN2), where Numb was widely
distributed in both the cytosol and the nucleus, whereas in
pTα-positive cells (DN3-DN4), Numb was preferentially asso-
ciated with the cell membrane and cytosol showing a nuclear
exclusion (Figure 1a), suggesting that Numb nuclear localiza-
tion is associated with early stages of T-cell development.
Onset of pre-T-cell receptor (pre-TCR) signaling at DN3 stage
is a crucial event during T-cell development, which regulates
proliferation, differentiation and survival of progenitors.
As Numb nuclear exclusion seems to be associated with
DN3-DN4 stage, we suggest a key role for pre-TCR signaling
in promoting nuclear exclusion of Numb. To test this
hypothesis, we used the T-cell receptor-β (TCRβ) chain-
deficient cell line SCIET27, lacking pre-TCR, derived from
severe-combined immunodeficient (SCID) mouse DN3
thymocytes,24 and the TCRβ chain stably transfected daughter
cell line SCB29, which express a functional pre-TCR. We
analyzed the Numb localization by using nuclear and cytosolic
fractionation assay. The efficiency of the subcellular fractiona-
tion method we used is shown in the Supplementary Figure 1.
Interestingly, in the absence of pre-TCR, Numb was highly
expressed in both nucleus and cytosol, whereas in the
presence of pre-TCR, Numb appears to be preferentially
localized in the cytosol, thus undergoing nuclear exclusion
(Figure 1b). Consistently, these results were confirmed by the
confocal microscopy analysis of Numb subcellular localization
performed on the same cells (Figure 1c).
Moreover, in thymocytes derived from pTα− /− mice, the
absence of pre-TCR signaling results in an exclusive Numb
nuclear localization (Figure 1d), although about 80% of the
thymocytes were DN3 (CD25+CD44−). These data were also
confirmed by confocal images, which show that CD44− DN3-
DN4 thymocytes from pTα− /− mice display a high Numb
nuclear localization (Figure 1e). Taken together, the data
reported above demonstrate that Numb localizes in the
nucleus of early thymocyte precursors and its nuclear
localization changes over time, where the appearance of
pre-TCR signaling at DN3 stage promotes nuclear exclusion.
Pre-TCR signaling regulates PKCθ-mediated Numb phos-
phorylation. Phosphorylation status has been shown to
regulate nuclear localization signal (NLS)-dependent nuclear
import.25 Interestingly, atypical protein kinase C (aPKC)-
mediated Numb phosphorylation has been described to
regulate Numb subcellular localization and membrane
polarization,26 influencing Numb function in neural27,28 and
epithelial cells.29 The role of aPKC is not conserved in
lymphocytes,30 whereas PKCθ has been shown to have key
roles in T-cell activation and proliferation.31 Thus, we wanted
to first analyze whether PKCθ is able to phosphorylate Numb.
Human embryonic kidney 293 (HEK293) cells were co-
transfected with Flag-Numb p66-expressing vector with or
without a constitutively active mutant of PKCθ (CA-PKCθ).
Immunoprecipitation of Flag-Numb p66 immunoblotted with a
specific antibody, named anti-P-serine PKC (anti-P-ser PKC)
substrate, which recognizes only the serine residues of
substrate proteins phosphorylated by PKC kinases,32 shows
that Numb p66 displays an increase in serine phosphoryla-
tion levels in the presence of CA-PKCθ (Figure 2a). As PKCθ
activity is regulated by pre-TCR signaling,33 we next sought
to determine whether Numb phosphorylation is influenced by
the presence of pre-TCR. Using an antibody that recognizes
the PKCθ phospho-threonine 538 (Thr538), which is phos-
phorylated only when PKCθ is activated,34 we found
increased PKCθ activation in pre-TCR-competent SCB29
cells when compared with pre-TCR-deficient SCIET27 cells
(Figure 2b, left panel). Accordingly, immunoprecipitation of
endogenous Numb in SCB29 and SCIET27 cells shows an
increment of phospho-serine-Numb in the presence of a
functional pre-TCR (Figure 2b, right panel). To discard a
redundant role between PKC isozymes expressed in
thymocytes, we used Rottlerin, a compound that specifically
inhibits PKCθ activity in T cells when it is used at a low
concentration (3 uM).35 The phospho-Numb levels decreased
in Rottlerin-treated SCB29 pre-TCR-competent cells when
compared with cells treated with the vehicle alone (Figure 2c,
left panel). The specificity of Rottlerin treatment was
confirmed using the anti-P-PKCθ Thr538 antibody, which
shows decreased PKCθ activity after treatment (Figure 2c,
left panel). Conversely, in the absence of pre-TCR, the
treatment with phorbol ester (phorbol-12-myristate-13-acet-
ate (PMA)), a potent activator of PKC in eukaryotic cells,
promotes an increase of phospho-Numb levels that corre-
lates with an increase of the PKCθ activity33 (Figure 2d).
Consistently, thymocytes from pTα− /− mice showed low
basal phosphorylation levels of Numb that were increased in
the presence of PMA (Figure 2e). Taken together, our data
demonstrate that Numb is a novel substrate of PKCθ in T-cell
context and its phosphorylation is under the regulation of pre-
TCR signaling.
Phosphorylation regulates Numb nuclear import. We
then investigated the presence of NLS in Numb protein by
using the program PSORT II. We identified two putative NLS
sequences, both located in the N-terminal region of the
protein including part of the phosphotyrosine-binding domain
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(PTB) domain (Supplementary Figure 2a). To determine the
contribution of these putative NLS sequences to the nuclear
import of Numb, we analyzed the ability of different Numb
mutants to migrate into the nucleus (Figure 3a). Mutants
containing the N-terminal region of the PTB domain were
able to localize in the nucleus, whereas the truncation mutant
lacking the N-terminal region (Numb-ΔN mutant), in which we
deleted both the NLS sequences predicted by PSORT II, was
defective in nuclear importing (Figure 3a, lower panel).
Interestingly, we found a putative PKC-dependent phosphor-
ylation site adjacent to the NLS at ninth position
(Supplementary Figure 2b), raising the possibility that the
subcellular localization of Numb is dependent on PKCθ-
mediated phosphorylation. By confocal microscopy analysis,
we analyzed the subcellular localization pattern of Numb
transfected in HEK293 cells in the presence or absence of
Figure 1 Numb subcellular distribution is dependent on pre-TCR. (a) Confocal images of wild-type (WT) fetal thymus E14d sections stained with antibodies against pTα (red)
and Numb (green), and treated with 4',6-diamidino-2-phenylindole (DAPI), which stains the nucleus (blue). Asterisks indicate the pTα-positive cells and arrows indicate the pTα−
cells. (Lower panels) Higher magnification of a single DN3 thymocyte (left) and DN2 thymocyte (right). (b and d) Cytosolic and nuclear fractions in (b, upper panel) SCB29 and
SCIET27 cells or (d) thymocytes derived from pTα− /− mice were revealed in western blot with anti-numb antibody. Anti-tubulin and anti-laminB antibodies were used as the
cytosol and nuclear markers, respectively. C, cytosolic fraction; N, nuclear fraction. (c and e) Confocal images of (c, upper panel) SCB29 and SCIET27 cells or (e) thymocytes
derived from pTα− /− mice stained with anti-numb (green or red), and treated with DAPI (blue). (b and c, lower panels) Relative Numb quantification of nuclear and cytosolic
Numb: NS, nonsignificant; P-value40.05. **P-valueo0.02. All data are representative of three independent experiments
Numb-dependent p53 function in T-cell development
NM Martin-Blanco et al
3
Cell Death and Disease
CA-PKCθ. As shown in Figure 3b, the co-transfection of CA-
PKCθ results in a marked increase of cytosolic Numb and a
decrease of nuclear Numb.
Confirming the above data, the inhibition of PKCθ by
Rottlerin in a pre-TCR-competent context resulted in a change
of Numb localization, promoting nuclear Numb accumulation
(Figure 3c). Accordingly, an opposite effect was observed
when PKCθ activity was mimicked in the absence of pre-TCR,
by using PMA: while cytosolic Numb levels increase, nuclear
Numb levels decrease markedly after PMA treatment of pre-
TCR negative SCIET27 cells (Figure 3d). Consistently, the
above results were also confirmed by confocal analysis
(Figure 3e). Taken together, these data suggest that PKCθ-
mediated Numb phosphorylation, once pre-TCR signaling is
triggered at DN3 stage, results in the subcellular redistribution
of Numb, promoting its nuclear exclusion.
Numb nuclear localization is essential for p53 stabiliza-
tion. It has been shown that Numb promotes p53 stabiliza-
tion blocking the function of the mouse double minute 2
(Mdm2) E3-ubiquitin ligase and, interestingly, both p53 and
Mdm2 are hosted in the nucleus.36 Western blot analysis in
SCB29 and SCIET27 cells revealed that Numb nuclear levels
were correlated with p53 levels, resulting in increased nuclear
p53 and its target p21 in SCIET27 cells, in which we observe
nuclear Numb, when compared with SCB29 cells, displaying
Numb nuclear exclusion (Figure 4a). Moreover, treatment of
SCIET27 cells with PMA, which activates PKCθ and
decreases Numb nuclear levels, was also able to promote a
decline in p53 level in the nucleus (Figure 4b). Notably, Numb
total levels increased after PMA treatment, suggesting that
p53 stabilization was dependent on nuclear Numb levels but
not on total Numb levels (Figure 4b, right panel). Accordingly,
similar results were obtained in thymocytes derived from
pTα− /− mice (Figure 4c). Next, we analyzed p53 stability
under different Numb localization conditions. Figure 4d
shows that overexpression of Numb in HEK293 cells disrupts
p53–Mdm2 interaction, resulting in a decrease of p53 poly-
and monoubiquitination after treatment with the proteasome
inhibitor MG132 (Figure 4e). In contrast, we observed that
upon Numb nuclear exclusion conditions, p53 does not
undergo stabilization. First, when ΔN-Numb mutant, which
shows nuclear exclusion (Figure 3a), was expressed,
Mdm2–p53 interaction and p53 ubiquitination were
comparable with that observed in the absence of ΔN-Numb
(Figures 4f and g), although ΔN mutant maintained the ability
to bind to Mdm2 and to be degraded as the WT Numb
(Supplementary Figures 3a and b). Second, coexpression of
Figure 2 PKCθ-dependent Numb phosphorylation is regulated by pre-TCR. (a) Co-transfection of HEK293 cells with Flag-Numb p66 with or without CA-PKCθ expression
plasmids. Whole-cell lysates were subjected to immunoprecipitation using anti-flag antibody and were revealed in western blot with anti-P-ser PKC substrate antibody. All samples
were supplemented with empty vector so that the final concentration of DNA was the same in all reactions. (b, left panel) Total cell lysates of SCB29 and SCIET27 cells were
resolved by western blot and incubated with anti-P-PKCθ (Thr538) and anti-β-actin antibodies. (Right panel) Endogenous Numb immunoprecipitates in whole-cell lysates of
SCB29 and SCIET27 cells were incubated with anti-P-ser PKC substrate and anti-numb antibodies to confirm that equal Numb amounts were immunoprecipitated. (c, right panel)
Numb immunoprecipitates in total lysates of non-treated or treated SCB29 cells with 3 uM of Rottlerin for 1 h were incubated with anti-P-ser PKC substrate and anti-numb
antibodies. (Left panel) Total cell lysates from the same experiment were incubated with anti-P-PKCθ (Thr538) and anti-β-actin antibodies. (d and e) Numb immunoprecipitates in
whole-cell lysates of (d) SCIET27 cells or (e) thymocytes from pTα− /−, treated or non-treated with 5 ng/ml of PMA for 1 h, were incubated with anti-P-ser PKC substrate and anti-
numb antibodies. All samples were supplemented with empty vector so that the final concentration of DNA was the same in all reactions. All data are representative of three
independent experiments
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Numb and PKCθ-CA, which results in Numb nuclear
exclusion, was not able to disrupt Mdm2–p53 complex or to
decrease p53 ubiquitination after MG132 treatment (Figures
4h and i). Next, we tested whether the modifications of p53
ubiquitination observed in the above experiments were linked
with its stabilization using the protein synthesis inhibitor
cycloheximide (CHX), to avoid the effect of new synthetized
factors. In these experimental conditions, neither the
Figure 3 Regulation of Numb nuclear localization by PKCθ. (a, upper panel) Schematic representation of Numb mutants. All constructs are tagged with Flag. (Lower panel)
Cytosolic and nuclear fractions of HEK293 cells transfected with Flag-Numb wild-type (WT) and Flag-Numb mutants were revealed in western blot with anti-flag and anti-β-actin
antibodies. (b, upper panel) Confocal imagines of HEK293 cells transfected with Numb p66 with or without CA-PKCθ and stained with anti-flag (green) and 4',6-diamidino-2-
phenylindole (DAPI) (blue) to detect nuclear Numb localization. (Lower panel) Relative Numb quantification of nuclear and cytosolic Numb or % of Numb in each compartment:
NS, nonsignificant; P-value40.05. **P-valueo0.02. (c and d) Cytosolic and nuclear fractions of (c) SCB29 treated with Rottlerin or (d) SCIET27 treated with PMA at different
times were revealed in western blot with anti-numb, anti-tubulin and anti-laminB antibodies. (c, right panel) Relative Numb quantification of nuclear Numb. **P-valueo0.02.
(e) Confocal images of SCB29 (upper panels) and SCIET27 (lower panels) cells stained with anti-numb (green) and DAPI (blue), treated or untreated with Rottlerin and PMA for
3 h, respectively. Right panels show the relative quantification of Numb in both the nucleus and cytosol, and the relative amount of Numb in the nucleus versus cytoplasm (ratio N/
C). C, cytosolic fraction; N, nuclear fraction. Anti-tubulin and anti-laminB antibodies were used as markers of the cytosol and nucleus, respectively. All data are representative of
three independent experiments
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Figure 4 Numb nuclear localization regulates p53 stabilization. (a) Cytosolic and nuclear fractions of SCB29 and SCIET27 cells were revealed by western blot with anti-p53,
anti-p21 and anti-numb antibodies. (b and c, left panels) Cytosolic and nuclear fractions of (b) SCIET27 cells and (c) pTα− /− thymocytes treated with PMA at different times were
revealed by western blot with anti-p53, anti-p21 and anti-numb antibodies. (Right panels) Total lysates of (b) SCIET27 cells and (c) thymocytes derived from pTα− /− treated with
PMA were revealed in western blot with anti-numb, anti-tubulin or anti-β-actin antibodies. (d, f and h) Whole-cell lysates of HEK293 cells transfected with Flag-p53 and Mdm2,
(d) with or without Flag-Numb p66, (f) with or without Flag-NumbΔN mutant or (h) with Flag-Numb p66 in the presence or absence of CA-PKCθ, were immunoprecipitated using
an antibody against Mdm2 and were revealed in western blot with anti-flag (p53) and anti-Mdm2 antibodies. (Lower panels) Western blot of Numb and p53 on whole-cell extracts
from (d, f and h). (e, g, i and j) Whole-cell lysates of HEK293 cells transfected with Flag-p53, Mdm2 and HA-ubiquitin, (e) with or without Flag-Numb p66, (g) with or without Flag-
Numb ΔN mutant, (i) with Flag-Numb p66 in the presence or absence of CA-PKCθ or (j) with or without Myc-PTB Numb, and treated with 30 μM MG132 for 4 h, were
immunoprecipitated using an anti-p53 antibody and revealed in western blot with anti-HA (against HA-flagged ubiquitin) and anti-p53 antibodies. All samples were supplemented
with empty vector so that the final concentration of DNA was the same in all reactions. C, cytosolic fraction; N, nuclear fraction. Anti-tubulin and anti-laminB antibodies were used
as markers of the cytosol and nucleus, respectively. All data are representative of three independent experiments
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overexpression of WT Numb together with CA-PKCθ nor the
one that of ΔN-Numb mutant alone (Supplementary Figure
3c, lanes 3 and 4) was able to stabilize p53 protein, resulting
in the same degradation rate than in the absence of Numb
(Supplementary Figure 3c, lane 1), whereas in the presence
of overexpressed WT Numb alone (Supplementary Figure 3c,
lane 2), p53 was completely stabilized, as expected. Taken
together, these results show that Numb nuclear import is
essential for Numb-mediated p53 stabilization.
Notably, Numb PTB peptides have been used to block
Mdm2 function and consequently to stabilize p53-mimicking
Numb function.37 We confirm here that Numb PTB mutant
retains the ability to interact with Mdm2 (Supplementary
Figure 4a). In addition, overexpression of Numb PTB was able
to stabilize p53, by decreasing its ubiquitination in comparable
manner, with respect to WT Numb overexpression (Figure 4j).
Interestingly, Numb PTB nuclear localization was independent
of PKCθ activity, as CA-PKCθ did not affect the subcellular
localization pattern of PTBmutant (Supplementary Figure 4b).
Taken together, these data show that Numb nuclear function is
dependent on the PTB domain. Moreover, Numb PTB nuclear
localization appears not to be regulated by PKCθ, possibly
because of its small size (18 kDa), which may allow the cross
of nuclear membrane by diffusion.38
Nuclear localization of Numb promotes its own proteo-
somal degradation. As the turnover of Numb, similar to p53,
is also regulated by Mdm2,37 one likely cause of increase in
Numb total levels in the presence of activated PKC after PMA
treatment, which increases cytosolic levels of Numb (Figures
4b and c), is that the half-life of Numb could be coupled with
its nuclear localization, being dependent on its interaction
with Mdm2.
However, nuclear Numb degradation has not been reported
before. To address this issue, we compared Numb half-life in
SCB29 and SCIET27 cells, in which Numb display a
differential subcellular localization pattern. Our analysis
revealed a correspondence between the localization and the
degradation rate of Numb. Indeed, SCB29 cells, where Numb
was cytosolic, displayed a higher Numb stability, whereas in
SCIET27 cells, where Numb was localized in the nucleus,
Numb was rapidly degraded (Figure 5a). Pharmacologic
treatments, which decrease or increase PKCθ activity,
changed Numb localization pattern and impact in the half-life
of Numb; when SCB29 cells were treated with Rottlerin in the
presence of CHX, there was a significant decline in the half-life
of Numb protein (Figure 5b). Interestingly, longer exposition to
Rottlerin markedly decreased both cytosolic and nuclear
levels of Numb in SCB29 cells and this effect was reversed
in the presence of MG132, which revealed a Numb accumula-
tion in the nuclear compartment (Figure 5c), showing that the
downmodulation of Numb is because of its nuclear proteoso-
mal degradation. The opposite effect was observed in
SCIET27 cells treated with PMA, where the half-life of Numb
displayed an increase (Figure 5d).
Enforced Numb nuclear function during DN3 stage
inhibits T-cell precursors' differentiation. Next, we ana-
lyzed the localization of Numb during DN3 stage, after a
fluorescent-activated cell sorting of total DN thymocytes
derived from WT Numb, transgenic mice overexpressing full-
length Numb (Numb TG) and transgenic mice overexpressing
the myc-tagged Numb PTB domain (Numb PTB TG).11 As
DN1-DN2 thymocytes are CD44 positives and DN3-DN4 are
CD44 negatives, we performed a CD44 staining of isolated
DN cells to discriminate between these sub-populations.
Confocal images revealed that overexpression of full-length
Figure 5 Nuclear degradation of Numb. (a) SCB29 or SCIET27 cells were treated with CHX in a time-course study (0–2–4 h) before lysis. Whole-cell lysates were revealed in
western blot with anti-numb and anti-β-actin antibodies. (b, left panel) SCB29 cells were treated with CHX at different times in the absence or presence of Rottlerin and whole cell
lysates were revealed in western blot with anti-numb and anti-β-actin antibodies. (Right panel) Relative quantification of Numb modulation determined by optical densitometry
(OD); quantification was normalized using β-actin levels. (c) Nuclear and cytosolic fractions of SCB29 cells treated with Rottlerin (Rott.) or DMSO, or Rottlerin plus MG132 for 12 h
were revealed in western blot with anti-numb antibody, using anti-tubulin and anti-laminB antibodies as the cytosol and nucleus markers, respectively. (d, left panel) SCIET27 cells
were treated with CHX at different times in the absence or presence of PMA and whole cell lysates were revealed in western blot with anti-numb and anti-β-actin antibodies. (Right
panel) Relative quantification of Numb modulation determined by OD. **P-valueo0.02 and *P-valueo0.05. C, cytosolic fraction; N, nuclear fraction. All data are representative
of three independent experiments
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Numb in Numb TG did not affect the subcellular localization
of Numb at DN3 stage (CD44− cells) when compared with
WT thymocytes, maintaining the nuclear exclusion at this
stage. Conversely, Numb PTB retained the ability to localize
in the nucleus during DN3 stage despite the presence of pre-
TCR, confirming our results above (Figure 6a), and it was
comparable to that one of full-length Numb in thymocytes
from pTα− /− mice, being mostly nuclear (Figure 6a). These
data were also confirmed by using nuclear–cytosol fractio-
nated extracts from total thymocytes derived from the same
mice (Figure 6b). We further analyzed the thymus phenotype
of different mutant mice. Interestingly, phenotype analysis of
thymocytes from Numb PTB transgenic and pTα− /− mice
revealed a correlation between the presence of Numb or
Numb PTB in the nucleus at DN3 stage and the increased
percentage in CD25+ CD44− DN3 cells and decreased
percentage of CD25− CD44− DN4 cells, suggesting a block in
T-cell differentiation at DN3 stage. Conversely, nuclear
exclusion of Numb at DN3 stage in WT and Numb TG mice
correlated with the predicted normal T-cell development and
differentiation observed in these mice (Figure 6c). In keeping
with this, we observed that while overexpression of WT Numb
in Numb TG thymocytes does not alter the expression levels
of p53 and p21, when compared with wild-type thymocytes,
overexpression of Numb PTB instead increased both p53 and
p21 nuclear levels in thymocytes (Figure 6d), similar to what
we observed in pre-TCR loss conditions. Moreover, the
increased p53 and p21 levels observed correlate with an
increased cell death by apoptosis of DN3 cells measured by
Annexin V staining (Figure 6e). Therefore, inhibition of Numb
nuclear function mediated by pre-TCR signaling appears to
be essential during DN3 stage to promote proper thymocytes
survival and differentiation.
Discussion
During development, Numb exerts two different roles that may
seem opposite, as it maintains progenitor fate and promotes
cell differentiation.6 This makes it difficult to understand which
pathways are regulated byNumb and raises the possibility that
these different roles are mediated by diverse Numb functions.
In this report, we demonstrate that Numb extends its capacity
to the regulation of p53 function during T-cell development.
Our data provide evidence for a model, where the different
subcellular localization patterns of Numb may reciprocally
regulate p53 and its own stability. In this model, the presence
and function of pre-TCR signaling at DN3 stage, by promoting
the nuclear exclusion of Numb, is responsible of the p53
downmodulation, necessary to allow the survival of DN3
thymocytes, and thus to continue their differentiation
(Figure 7). This is in agreement with previous reports where
p53 downmodulation has been suggested to be a pre-TCR
triggering downstream event.20,21 Notably, loss of pre-TCR
signaling in SCID, RAG− /− and CD3γ− /− mice21 promotes a
block of thymocyte differentiation at DN3 stage, associated
with an increase of p53 levels. In keeping with this, our data
show that the absence of pre-TCR signaling in thymocytes
from pTα− /− mice promotes a nuclear Numb accumulation at
DN3 stage, which result in high levels of p53, a block at DN3
stage, an increase in cell death by apoptosis, and
consequently a small thymus size. Interestingly, Numb PTB
TG mice, where nuclear Numb function is maintained
during DN3 stage, show a similar phenotype. Notably,
Mdm2 puro/Δ7− 12 mice,39 where the level of Mdm2 expression
is decreased, showan increment of p53 levels associated with
a block of thymocyte differentiation similar to that one
observed in Numb PTB TG mice. Moreover, high levels of
p53 expression are observed in thymocytes of embryonic
thymus from E14.5 to E16.5.40 Notably, we show that the high
levels of p53 expression in the thymus of E14.5 mice correlate
with the presence of nuclear Numb in such age thymus. All
these data suggest that Numb nuclear function during T-cell
development is finely regulated by its localization. However, it
appears to be independent of total Numb levels as we
observed that overexpression of Numb in Numb TG mice
does not affect its nuclear function. This is also in agreement
with previous data where overexpression of Numb does not
influence cell survival.41 Our findings suggest that the main
role of Numb in T-cell development could be focused on p53
regulation. In this scenario, the absence of Numb is expected
to impair p53 stabilization but not to alter T-cell specification,
as previous data have shown,9 as loss of p53 apparently does
not affect thymocyte development.22
Data from other cell systems in which Numb function has
been studied in detail reveal that the dual role of Numb is
regulated based on its interaction with ACBD3, a Golgi-
associated protein.7 ACBD3 has been described to hold its
targets within cytosol during mitosis, by inhibiting their
translocation into the nucleus.42 Moreover, Numb AB domain
is responsible of Numb–ACBD3 interaction. Notably, we show
here that the NLS of Numb is hosted in this domain, thus
raising the interesting possibility that cytosolic ACBD3 may
impinge on Numb nuclear translocation, finally inhibiting p53
activity and consequently promoting a change in Numb
function over time. Taken together, these observations allow
us to hypothesize that a similar mechanism may be active
during thymocyte differentiation, although the ACBD3 expres-
sion has not been reported in lymphocytes, as yet. Notably, Igl
mutant brains show an increase in cortical aPKC activity,
resulting in the deregulation of Numb phosphorylation. Under
these conditions, neuroblasts are not able to complete the
differentiation process.27 Interestingly, the phenotype exhib-
ited by Igl mutant is remarkably similar to that observed in
ACBD3 mutants, in which inhibition of nuclear function of
Numb may be responsible of an altered differentiation.
Overall, our data reveal important keys in the Numb function
regulation, where Numb function is exquisitely regulated
through its own subcellular distribution to balance alternative
pathways at different stages of development.
Materials and Methods
Mice. pTα − /−,43 Numb TG and Numb PTB TG mice11 have been described
elsewhere. The studies involving animals were conducted following Italian National
guidelines for animal care established in the Decree number 116 of 27 January
1992, in accord with the Directive CEE 86/609, as well as in the Circular number 8
of the Ministry of Health of 23 April 1994.
Flow cytometry. Thymocytes were washed two times in PBS and stained at
4 °C with antibodies, anti-CD44, anti-CD4, anti-CD8 and anti-CD25 (BD Bioscience,
San Jose, CA, USA). For Annexin V (BD Bioscience) analysis, the manufacturer's
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Figure 6 Numb localization regulates DN3 differentiation and death. (a, left panel) Confocal imagines of DN thymocytes sorted from wild-type (WT), Numb TG, Numb PTB
TG and pTα− /− mice and stained with anti-CD44 (red), anti-numb (green), anti-myc (green) (to reveal myc-tagged Numb PTB) and 4',6-diamidino-2-phenylindole (DAPI) (blue).
(Right panel) Relative quantification of cytosolic or nuclear Numb. (b, left panel) Cytosolic and nuclear extracts from WT, Numb TG, Numb PTB TG and pTα− /− thymocytes were
resolved by western blot with anti-numb and anti-myc antibodies. Anti-tubulin and anti-laminB antibodies were used as the cytosol and nucleus markers, respectively. (Right
panel) Relative quantification of Numb (black bars) or Numb PTB (gray bars) nuclear/cytosolic ratio determined by optical densitometry (OD); quantification was normalized using
tubulin and laminB levels. **P-valueo0.02. (c) CD25+ and/or CD44+ subset distribution of DN thymocytes from WT, Numb TG, Numb PTB TG and pTα− /− mice. Quadrants
represent DN1, DN2, DN3 and DN4 sub-populations (clockwise from top left to bottom left) and the numbers represent the percentage of each sub-population. (d) Nuclear
extracts from WT, Numb TG and Numb PTB TG mice were resolved by western blot with anti-p53, anti-p21 and anti-laminB antibodies. (e) Overlay of Annexin V flow cytometric
analysis of DN3 thymocytes from Numb TG and Numb PTB TG mice, compared with DN3 thymocytes from WT mice. The Annexin V MFI were calculated for DN3 cells from
WT= 20.4, Numb TG= 24.9 and Numb PTB TG= 43.1. All data are representative of three independent experiments
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instructions were used. Analysis was performed on a FACSCalibur (BD). Files were
analyzed with FlowJo Version 4.6.2 software (TreeStar Inc., Ashland, OR, USA).
Immunofluorescence and confocal microscopy. Fetal thymi were
fixed with 4% paraformaldehyde solution in PBS, treated with 20% sucrose solution
in PBS, immersed in OCT (Tissue Tek) and frozen with a mixture of 2-methylbutene
and dry ice. Sections (10 μm) were fixed, permeabilized with Triton X-100, blocked
in a solution containing 5% normal goat serum and 3% of bovine serum albumin
and stained in the same solution. Sections were mounted with ProLong Antifade
(Molecular Probes, Life Technologies Corporation, Carlsbad, CA, USA). Antibodies
used were as follows: anti-numb (Cell Signaling, Beverly, MA, USA), anti-CD44
Alexa-647 conjugated, anti-pTα (BD Bioscience), biotinylated anti-myc (Upstate
Biotechnology) and DAPI. We use a Leica TCS SP5 confocal microscope
with either x20 or x40 objective; images were collected at 8-bit depth,
with a resolution of 1024 × 1024 pixels. Images were processed using LAS AF
(Leica Microsystems) and Adobe Photoshop software (Adobe Systems, San Jose,
CA, USA). The software LAS AF (Leica Microsystem) was used to quantify
fluorescent images. Inside each cell, one gate for the nucleus, using DAPI as a
marker, and one gate for the cytosol was drawn and threshold intensities of total
pixels were determined for Numb.
Plasmids and cell transfection. Transient transfection experiments were
performed by TransFectin Lipid Reagent (Bio-Rad, Hercules, CA, USA) according to
the manufacturer's instructions. The expression vectors for CA-PKCθ,44 Flag-WT
Numb and Flag-Numb mutant,45 Myc-PTB Numb (provided by M Canelles), Flag-
p53, Mdm2 and HA-ubiquitin have been described elsewhere.
Cells lines and treatments. HEK293 cells were used for transient
transfection experiments. SCIET27 (TCRβ-deficient) and SCB29 (TCRβ-trans-
fected) cells24 were described previously. In similar cases, cells were treated with
different compounds. Thirty micromolar proteasome inhibitor MG132, 3 μM PKCθ
inhibitor Rottlerin (Calbiochem, Darmstadt, Germany), 10 μg/ml ribosome inhibitor
CHX (Sigma-Aldrich, St. Louis, MO, USA), 7.5 ng/ml nuclear export inhibitor
leptomycin B (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and 50 ng/ml PKC
activator PMA (Sigma-Aldrich) for the times indicated.
Protein extracts, immunoprecipitation and immunoblotting. Total
extracts and immunoprecipitations were performed as described previously.33
For immunoblotting, proteins were resolved by SDS-PAGE and blotted into the
nitrocellulose membrane. The blots were incubated with the following antibodies:
anti-β-actin, anti-HA, anti-myc and anti-flag were from Sigma-Aldrich; anti-tubulin,
anti-p53, anti-p21, anti-Mdm2 and anti-laminB were from Santa Cruz Biotechnology;
and anti-numb, anti-phospho-PKCθ (Thr538) and anti-P-ser PKC substrate were
from Cell Signaling.
Subcellular fractionation. Cells were resuspended in ice-cold hypotonic
buffer (10 mM KCl, 10 mM HEPES (pH 7.4), 10 mM NaCl, 0.1 mM EDTA, 1 mM
DTTand 0.5 mM PMSF) and incubated on ice for 15 min. A measure of 0.6% NP-40
was added and lysates were vortexed for 10 s. The lysates were centrifuged at
12 000 r.p.m. for 1 min to remove nuclei and cell debris, and the supernatant
(cytosol) was collected and centrifuged at 12 000 r.p.m. for 30 min at 4 °C. The pellet
was resuspended in hypotonic buffer with 0.6% of NP-40 and vortexed and washed
three times at 12 000 r.p.m. for 2 min at 4 °C. The pellet was resuspended in the
buffer (0.4 M NaCl, 20 mM HEPES (pH 7.4), 1 mM EDTA, 1 mM DTT and 1 mM
PMSF) and incubated on ice for 30 min. The lysates were centrifuged at 12 000 r.p.
m. for 30 min and the supernatant (nucleus) was collected.
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